Company:  BIOPHARMX CORP (BPMX)
Form Type:  S-3
Filing Date:  8/17/2017 
CIK:  0001504167 
Address:  1505 ADAMS DRIVE, SUITE D 
City, State, Zip:  MENLO PARK, California 94025 
Telephone:  650-889-5020 
Fiscal Year:  01/31 
Last Trade
Last Trade: 
$0.13  
Change: 
-0.0609 (-32.76%)  
Trade Time: 
Nov 21  
Market Cap: 
$9.96M
Trade BPMX now with 

© 2017  
Description of Business
We are a specialty pharmaceutical company focused on utilizing our proprietary drug delivery technologies to develop and commercialize novel prescription products that address large markets in dermatology. Our objective is to develop products that treat health or age­related conditions that: (1) are not presently being addressed or treated or (2) are currently treated with drug therapies or drug delivery approaches that are sub­optimal.
Register and access this filing in:     
  FORM S-3
    CALCULATION OF REGISTRATION FEE
    SUBJECT TO COMPLETION, DATED AUGUST 17, 2017
    TABLE OF CONTENTS
    RISK FACTORS
    DISCLOSURE REGARDING FORWARD-LOOKING STATEMENTS
    USE OF PROCEEDS
    SELLING STOCKHOLDERS
      BENEFICIAL OWNERS
      BENEFICIAL OWNERS
    DESCRIPTION OF SECURITIES
    Transfer Agent and Registrar
    PLAN OF DISTRIBUTION
    LEGAL MATTERS
    EXPERTS
    WHERE YOU CAN FIND MORE INFORMATION
      INCORPORATION OF DOCUMENTS BY REFERENCE
    PART II
      Item 14. Other Expenses of Issuance and Distribution.
      Item 15. Indemnification of Officers and Directors.
      Item 16. Exhibits.
      Item 17. Undertakings.
    SIGNATURES
  EXHIBIT 5.1
  EXHIBIT 23.1
    CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM